Archie Prentice

A comparison of low‐dose cytarabine and hydroxyurea with or without all‐trans retinoic acid for acute myeloid leukemia and high‐risk myelodysplastic syndrome in patients not considered fit for intensive treatment

Alan K. Burnett, Donald Milligan, Archie Prentice et al. · Cancer · 2007 · 613 citations · Full text

Curability of Patients With Acute Myeloid Leukemia Who Did Not Undergo Transplantation in First Remission

Alan K. Burnett, Anthony P. Goldstone, Robert K. Hills et al. · Journal of Clinical Oncology · 2013 · 204 citations · Full text

Improving the effectiveness of multidisciplinary team meetings for patients with chronic diseases: a prospective observational study

Rosalind Raine, Isla Wallace, Caoimhe Nic a’ Bháird et al. · Health Services and Delivery Research · 2014 · 97 citations · Full text

Counseling, Disease Management, Clinical Decision-making +24

Multiple dose pharmacokinetics of an oral solution of itraconazole in autologous bone marrow transplant recipients

Archie Prentice, David W. Warnock, S.A. Johnson et al. · Journal of Antimicrobial Chemotherapy · 1994 · 92 citations

The Addition of Gemtuzumab Ozogamicin to Induction Chemotherapy for AML Improves Disease Free Survival without Extra Toxicity: Preliminary Analysis of 1115 Patients in the MRC AML15 Trial.

Alan K. Burnett, William J. Kell, Anthony H. Goldstone et al. · Blood · 2006 · 78 citations